# Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. – FDA Inspection, May 17, 2013

Source: https://www.keypedia.com/records/fda_inspections/onyx-pharmaceuticals-inc-a-subsidiary-of-amgen-inc/36ebbabe-f6d5-4348-8b91-653621fd01ca
Source feed: FDA_Inspections

> FDA inspection 833837 of Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc., May 17, 2013. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 314. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 833837
- Company Name: Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc.
- Inspection Date: 2013-05-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 914497 - 2015-02-06
- [FDA Inspection 765467 - 2012-01-20](https://www.keypedia.com/records/fda_inspections/onyx-pharmaceuticals-inc-a-subsidiary-of-amgen-inc/1a73ad03-4282-4023-aab8-00cb7d7d3c5b)

Company: https://www.keypedia.com/companies/onyx-pharmaceuticals-inc-a-subsidiary-of-amgen-inc/99535d65-fff9-419e-bf57-d11ae158e2e4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c